Tuvalu
Diabetes country report 2011 — 2050
Number of adults (20–79 years) with diabetes in Tuvalu (TV)
2011 | 1.1 thousand |
2024 | 1.2 thousand |
2050 | 1.5 thousand |
Tuvalu is one of the 37 countries and territories in the Western Pacific Region.
Data source(s) used for the diabetes estimates in adults:
- Estimates extrapolated from Fiji, Marshall Islands and Palau.
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | - | 1.1 | 1.2 | 1.5 |
Age-standardised prevalence of diabetes, % | - | 19.2 | 19.0 | 21.3 |
Proportion of people with undiagnosed diabetes, % | - | - | 56.3 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 0.7 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 0.9 | 1.1 |
Age-standardised prevalence of IFG, % | - | - | 13.5 | 13.9 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 0.5 | 0.5 | 0.6 |
Age-standardised prevalence of IGT, % | - | 8.9 | 7.7 | 8.4 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 21.0 | 8.5 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 15.2 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 2.1 | 2.7 |
Total diabetes-related health expenditure, ID million | - | - | 2.3 | 2.9 |
Diabetes-related health expenditure per person, USD | - | 377.0 | 1,772.3 | 1,789.3 |
Diabetes-related health expenditure per person, ID | - | - | 1,939.4 | 1,958.0 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | - | - |
People with type 1 diabetes (0-19 y) | - | - | - | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | - | 5.7 | 6.7 | 8.2 |
Population of children and adolescents (0-19 y) | - | - | - | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | - |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | - |
Population of children and adolescents (0-19 y) | - |